| Product Code: ETC13176605 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
Asia Vaccines Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Asia Vaccines Market Overview |
3.1 Asia Regional Macro Economic Indicators |
3.2 Asia Vaccines Market Revenues & Volume, 2021 & 2031F |
3.3 Asia Vaccines Market - Industry Life Cycle |
3.4 Asia Vaccines Market - Porter's Five Forces |
3.5 Asia Vaccines Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 Asia Vaccines Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.7 Asia Vaccines Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.8 Asia Vaccines Market Revenues & Volume Share, By Disease Indication, 2021 & 2031F |
3.9 Asia Vaccines Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.10 Asia Vaccines Market Revenues & Volume Share, By Patient Type, 2021 & 2031F |
4 Asia Vaccines Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Asia Vaccines Market Trends |
6 Asia Vaccines Market, 2021 - 2031 |
6.1 Asia Vaccines Market, Revenues & Volume, By Technology, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Asia Vaccines Market, Revenues & Volume, By Conjugate vaccines, 2021 - 2031 |
6.1.3 Asia Vaccines Market, Revenues & Volume, By Inactivated and subunit vaccines, 2021 - 2031 |
6.1.4 Asia Vaccines Market, Revenues & Volume, By Live attenuated vaccines, 2021 - 2031 |
6.1.5 Asia Vaccines Market, Revenues & Volume, By Recombinant vaccines, 2021 - 2031 |
6.1.6 Asia Vaccines Market, Revenues & Volume, By Toxoid vaccines, 2021 - 2031 |
6.2 Asia Vaccines Market, Revenues & Volume, By Type, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Asia Vaccines Market, Revenues & Volume, By Monovalent vaccines, 2021 - 2031 |
6.2.3 Asia Vaccines Market, Revenues & Volume, By Multivalent vaccines, 2021 - 2031 |
6.3 Asia Vaccines Market, Revenues & Volume, By Disease Indication, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Asia Vaccines Market, Revenues & Volume, By Pneumococcal disease, 2021 - 2031 |
6.3.3 Asia Vaccines Market, Revenues & Volume, By DTP, 2021 - 2031 |
6.3.4 Asia Vaccines Market, Revenues & Volume, By Influenza, 2021 - 2031 |
6.3.5 Asia Vaccines Market, Revenues & Volume, By HPV, 2021 - 2031 |
6.3.6 Asia Vaccines Market, Revenues & Volume, By Meningococcal disease, 2021 - 2031 |
6.3.7 Asia Vaccines Market, Revenues & Volume, By Polio, 2021 - 2031 |
6.3.8 Asia Vaccines Market, Revenues & Volume, By Rotavirus, 2021 - 2031 |
6.3.9 Asia Vaccines Market, Revenues & Volume, By Other disease indications, 2021 - 2031 |
6.4 Asia Vaccines Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Asia Vaccines Market, Revenues & Volume, By Intramuscular and subcutaneous administration, 2021 - 2031 |
6.4.3 Asia Vaccines Market, Revenues & Volume, By Oral administration, 2021 - 2031 |
6.4.4 Asia Vaccines Market, Revenues & Volume, By Other routes of administration, 2021 - 2031 |
6.5 Asia Vaccines Market, Revenues & Volume, By Patient Type, 2021 - 2031 |
6.5.1 Overview & Analysis |
6.5.2 Asia Vaccines Market, Revenues & Volume, By Pediatric patients, 2021 - 2031 |
6.5.3 Asia Vaccines Market, Revenues & Volume, By Adult patients, 2021 - 2031 |
7 Asia Vaccines Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 Asia Vaccines Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.2.1 India Vaccines Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.2.2 China Vaccines Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.2.3 Japan Vaccines Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.2.4 South Korea Vaccines Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.2.5 Australia Vaccines Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.2.6 Thailand Vaccines Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.2.7 Vietnam Vaccines Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.2.8 Indonesia Vaccines Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.2.9 Philippines Vaccines Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.2.10 Rest of Asia Vaccines Market, Revenues & Volume, By Technology, 2021 - 2031 |
7.3 Asia Vaccines Market Revenues & Volume Share, By Type, 2021 & 2031F |
7.3.1 India Vaccines Market, Revenues & Volume, By Type, 2021 - 2031 |
7.3.2 China Vaccines Market, Revenues & Volume, By Type, 2021 - 2031 |
7.3.3 Japan Vaccines Market, Revenues & Volume, By Type, 2021 - 2031 |
7.3.4 South Korea Vaccines Market, Revenues & Volume, By Type, 2021 - 2031 |
7.3.5 Australia Vaccines Market, Revenues & Volume, By Type, 2021 - 2031 |
7.3.6 Thailand Vaccines Market, Revenues & Volume, By Type, 2021 - 2031 |
7.3.7 Vietnam Vaccines Market, Revenues & Volume, By Type, 2021 - 2031 |
7.3.8 Indonesia Vaccines Market, Revenues & Volume, By Type, 2021 - 2031 |
7.3.9 Philippines Vaccines Market, Revenues & Volume, By Type, 2021 - 2031 |
7.3.10 Rest of Asia Vaccines Market, Revenues & Volume, By Type, 2021 - 2031 |
7.4 Asia Vaccines Market, Revenues & Volume, By Disease Indication, 2021 - 2031 |
7.4.1 India Vaccines Market, Revenues & Volume, By Disease Indication, 2021 - 2031 |
7.4.2 China Vaccines Market, Revenues & Volume, By Disease Indication, 2021 - 2031 |
7.4.3 Japan Vaccines Market, Revenues & Volume, By Disease Indication, 2021 - 2031 |
7.4.4 South Korea Vaccines Market, Revenues & Volume, By Disease Indication, 2021 - 2031 |
7.4.5 Australia Vaccines Market, Revenues & Volume, By Disease Indication, 2021 - 2031 |
7.4.6 Thailand Vaccines Market, Revenues & Volume, By Disease Indication, 2021 - 2031 |
7.4.7 Vietnam Vaccines Market, Revenues & Volume, By Disease Indication, 2021 - 2031 |
7.4.8 Indonesia Vaccines Market, Revenues & Volume, By Disease Indication, 2021 - 2031 |
7.4.9 Philippines Vaccines Market, Revenues & Volume, By Disease Indication, 2021 - 2031 |
7.4..10 Rest of Asia Vaccines Market, Revenues & Volume, By Disease Indication, 2021 - 2031 |
7.5 Asia Vaccines Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.5.1 India Vaccines Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.5.2 China Vaccines Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.5.3 Japan Vaccines Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.5.4 South Korea Vaccines Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.5.5 Australia Vaccines Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.5.6 Thailand Vaccines Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.5.7 Vietnam Vaccines Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.5.8 Indonesia Vaccines Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.5.9 Philippines Vaccines Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.5.10 Rest of Asia Vaccines Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.6 Asia Vaccines Market, Revenues & Volume, By Patient Type, 2021 - 2031 |
7.6.1 India Vaccines Market, Revenues & Volume, By Patient Type, 2021 - 2031 |
7.6.2 China Vaccines Market, Revenues & Volume, By Patient Type, 2021 - 2031 |
7.6.3 Japan Vaccines Market, Revenues & Volume, By Patient Type, 2021 - 2031 |
7.6.4 South Korea Vaccines Market, Revenues & Volume, By Patient Type, 2021 - 2031 |
7.6.5 Australia Vaccines Market, Revenues & Volume, By Patient Type, 2021 - 2031 |
7.6.6 Thailand Vaccines Market, Revenues & Volume, By Patient Type, 2021 - 2031 |
7.6.7 Vietnam Vaccines Market, Revenues & Volume, By Patient Type, 2021 - 2031 |
7.6.8 Indonesia Vaccines Market, Revenues & Volume, By Patient Type, 2021 - 2031 |
7.6.9 Philippines Vaccines Market, Revenues & Volume, By Patient Type, 2021 - 2031 |
7.6.10 Rest of Asia Vaccines Market, Revenues & Volume, By Patient Type, 2021 - 2031 |
8 Asia Vaccines Market Key Performance Indicators |
9 Asia Vaccines Market - Export/Import By Countries Assessment |
10 Asia Vaccines Market - Opportunity Assessment |
10.1 Asia Vaccines Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 Asia Vaccines Market Opportunity Assessment, By Technology, 2021 & 2031F |
10.3 Asia Vaccines Market Opportunity Assessment, By Type, 2021 & 2031F |
10.4 Asia Vaccines Market Opportunity Assessment, By Disease Indication, 2021 & 2031F |
10.5 Asia Vaccines Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
10.6 Asia Vaccines Market Opportunity Assessment, By Patient Type, 2021 & 2031F |
11 Asia Vaccines Market - Competitive Landscape |
11.1 Asia Vaccines Market Revenue Share, By Companies, 2022 |
11.2 Asia Vaccines Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here